The relationship between the use of complementary therapy (CT) and satisfaction with medical treatment decision making and with the treating oncologist was evaluated in a sample of 166 women who were undergoing an initial course of chemotherapy for early-stage breast cancer. At the beginning of chemotherapy, 39% indicated already trying CT and an additional 13% reported planning to try CT. These women mentioned a variety of vitamin, nutritional, herbal, physical, mental, and spiritual approaches. Four months later, when most patients had completed chemotherapy, more than half (53%) reported using CT, with another 8% planning to try it. Regression analysis controlling for psychosocial and medical variables revealed that women who were younger and less satisfied with their treatment decisionmaking experience were significantly more likely to use CT. When predicting use of CT at the conclusion of treatment, baseline utilization was the greatest predictor, but dissatisfaction with the oncologist was also a significant predictor. These findings suggest that patients who are dissatisfied with their medical care may be more likely to use CT during treatment. Further research is needed to elucidate the relationship between satisfaction with medical decision making and the patient-physician relationship to CT use among cancer patients. The findings also highlight the importance of good patient-physician communication about CT use throughout the cancer treatment experience.
have higher levels of education and income. 3, 4, 15, 20, [25] [26] [27] [28] In terms of medical history, CT utilization appears to be more likely among women with late-stage breast cancer than among those with early-stage cancer. 5, 20 With regard to health and social behaviors, Lee et al 5 found that regular exercise, not smoking and social integration (eg, involvement in community or religious groups), predicts CT use. CT use among breast cancer patients has also been associated with attending a support group. 22 Finally, some research has suggested that a patients' emotional state may influence the use of CT; for example, patients experiencing greater distress are more likely to try to seek out some form of CT. 27, 29 However, findings in this area are inconsistent in that other studies have found no relationship between affective state and CT use. 30 
Motives Underlying CT Use
Several reasons underlying the impetus to use CT have been reported, including patients' need for autonomy and control of their cancer experience, preference for holistic or natural therapy, hope for cure or prevention of recurrence, and the amelioration of side effects. Other potential reasons for use include boosting the immune system, improving well-being, and alleviating physical or emotional distress. 17, 20, 21, [25] [26] [27] There have been few reports that address the relationship of cancer patients' satisfaction with medical care to their use of CT. In a recent literature review of the reasons for CT use among adult cancer patients, Verhoef et al 31 summarized 52 articles and found that disappointment with a conventional practitioner or conventional treatment was mentioned in only 2 (3.8%) studies. Dissatisfaction with conventional medicine 20 and, more specifically, dissatisfaction with physicians 24, 32 have been cited as predictors of CT use among breast cancer patients. However, in another study, no association was found between CT use and satisfaction with health care providers among women with breast cancer. 33 Hann et al 26 reported that among a sample of 126 breast cancer patients who engaged in CT during active treatment, 17% reported using CT because they were "not satisfied with conventional treatment," and 10% used CT because they "had a negative experience with conventional treatment." Also from this report, 36% of the patients used CT because they "wanted a more involved relationship with a practitioner"; this latter reason may imply some degree of dissatisfaction with the relationship with their oncologist, although this was not further investigated.
Medical Decision Making and the Patient-Physician Relationship
A positive patient-physician relationship and open communication are of key importance to the medical decision-making process. [34] [35] [36] Positive patient-physician interaction has been shown to be associated with patient satisfaction with medical care, favorable attitudes toward physicians, recall and understanding of information, adherence to treatment, improved emotional well-being, and better overall health status. [35] [36] [37] [38] [39] The results of a focus group study suggest that the physician-patient relationship can be problematic, however, for younger (defined as younger than 50 years) women with breast cancer. 11 Research on other patient populations shows that poor communication between physicians and patients is significantly associated with high levels of anxiety, distrust of health care providers, suspicion of therapy recommendations, and dissatisfaction with medical services [40] [41] [42] [43] [44] ; these factors may influence patients to try CT.
In our review of the literature, no studies were found that specifically addressed the relationship between breast cancer patients' use of CT and their satisfaction with medical treatment decision making and/or with their oncologist. Both indices of satisfaction (ie, breast cancer patients' satisfaction with their experience while making important treatmentrelated decisions prior to chemotherapy and their satisfaction with the treating oncologist at the end of chemotherapy) may provide unique insights into possible motivations for CT use in this population.
Materials and Methods

Sample
This sample was recruited as part of a randomized trial evaluating the efficacy of a problem-solving stressreduction intervention designed to help younger (<50 years) breast cancer patients cope with their diagnosis and treatment. 45 Eligible patients were recruited from a network of sites in Rhode Island, southeastern Massachusetts, Philadelphia, and Newark, New Jersey, between April 1996 and November 1999. Study eligibility criteria included women aged 50 or younger who had no prior history of breast cancer, who had a tissueconfirmed diagnosis of stage I to IIIA tumors, and who were initiating their first course of chemotherapy treatment. These criteria were selected to ensure reasonable homogeneity in women's disease and treatment experience (eg, women with metastatic disease may be offered different treatment protocols than women with earlier stage disease).
Procedures
The research protocol was approved by Brown University and by the Institutional Review Board at each recruitment site. Participating medical oncologists and/or their office personnel provided information about the study to eligible patients on an ongoing basis. Women who expressed interest in learning more about the study were contacted by project staff for consent. Respondents participated in a 1-hour baseline telephone interview approximately 4 weeks after starting chemotherapy (N = 166). For follow-up, women were reinterviewed 4 months later (n = 154), when most were expected to have completed chemotherapy treatment. As part of the baseline assessment, patients were interviewed about their use of CT and their satisfaction with the treatment decision-making process. At follow-up, patients were asked about their CT use and their satisfaction with their treating medical oncologist.
Measures
Use of CT was assessed by asking patients, "Have you tried complementary/alternative therapies, such as acupuncture, healing stones, herbs, vitamins or special diets?" and if not, "are you planning to do so?" Use of CT was defined as a dichotomous variable (0 = no, 1 = yes).
In addition, patients were asked to indicate which therapies they had used or were planning to use. In this way, women were defining CT for themselves; responses included a variety of CT methods that women might consider, including dietary changes and prayer. Responses were assigned by 2 independent raters to 1 of 7 categories: dietary, vitamins, herbal, physical, cognitive, spiritual, and other. It should be noted that these analyses were conducted prior to the introduction of more standard categories now offered by the American Cancer Society 46 and the National Institutes of Health. 47 However, these 7 categories are within the broader scope of CT use and were considered appropriate for this report.
Satisfaction with medical decision making was assessed with a 5-item index designed for this project (α reliability = .70). Respondents were asked to indicate their level of agreement with the following statements (1 = strongly agree, 4 = strongly disagree): (1) I had enough time to make treatment decisions, (2) I would have liked more information about treatment choices, (3) I would have liked more information about treatment side effects, (4) I would have liked help with knowing what questions to ask, and (5) I participated in treatment decisions as much as I wanted. To calculate a total satisfaction score, items 1 and 5 were reverse scored; scores could range from 5 to 20, with higher scores indicating greater satisfaction.
Satisfaction with the treating oncologist was assessed using a 1-item index asking patients, "Overall, how satisfied (are/were) you with the medical oncologist who (is/was) involved in your chemotherapy treatment?" Respondents were asked to indicate if they were very satisfied (1), somewhat satisfied (2), neither satisfied nor dissatisfied (3), somewhat dissatisfied (4), or very dissatisfied (5) . Patients were also asked in an openended fashion for reasons for their dissatisfaction with their medical oncologist. These reasons were coded and categorized by 2 independent raters into 6 categories: (the physician) did not answer questions or provide information, did not provide clear explanations, did not advocate for or support the patient, did not accommodate the patient's needs, was not competent in providing treatment, and was not compassionate, sympathetic, or courteous.
In addition to data on demographic and medical characteristics, information collected at the baseline assessment on several psychosocial variables associated with CT use were also included in the analyses. First, since taking an active role in the cancer experience has been associated with CT use, 48,49 2 indicators of active participation were included: seeking a second medical opinion and attendance in a support group. Also, since emotional distress has been associated with CT use, 27 the MHI-5, a standard measure of emotional distress, was included in the analyses. The MHI-5 is a 5-item subscale of the well-validated Medical Outcomes Study 36-Item Short Form General Health Survey. 50 Weighted index scores range from 0 to 100, with higher values indicating better emotional health.
Statistical Analyses
The relationship between each of the satisfaction variables (ie, satisfaction with the medical decision-making process at baseline and satisfaction with one's oncologist at follow-up) to the use of CT was examined using analysis of variance (ANOVA). Also, these relationships were examined using logistic regression analyses; in these analyses, the control variables included age, race (0 = white, non-Hispanic; 1 = other), marital status (0 = spouse or significant other; 1 = other), education (0 = college degree; 1 = other), employment (0 = currently working; 1 = other), income (0 = annual income more than $60 000; 1 = other), stage of cancer (0 = stage I or II; 1 = stage III or above), whether or not patients obtained a second opinion (0 = no; 1 = yes), attendance in a support group (0 = no; 1 = yes), MHI-5 score (0-100), and use of CT at baseline. Finally, because these data were collected as part of a clinical trial, a variable to identify participants in the experimental group (1) or control group (0) in the original study was included.
Results
The study sample is described in Table 1 . The mean age of the respondents was 42.3 years (SD = 5.3). Most of the women were white (83%), either married or in a significant relationship (72%), and employed at least part-time (75%). A fair proportion of respondents (41%) held a college degree, and 39% had household incomes greater than $60 000.
Most respondents (84%) had either stage I or stage II breast cancer, and 52% had undergone a mastectomy. Just more than half of the respondents (52%) reported seeking a second medical opinion, and 17% of respondents were attending a cancer support group at the start of chemotherapy. With regard to emotional distress, the mean MHI-5 score for the entire sample was 65.0 (SD = 16.5; range, 16-95).
Use and Types of CT
At baseline, 39% of the respondents had tried CT, and 13% were planning to try CT. Most women reported improving the nutritional value of their diets (54%), followed by the use of vitamins (44%), herbal methods (44%), physical methods such as acupuncture and massage (18%), cognitive methods such as meditation (11%), and spiritual methods such as prayer (6%).
At follow-up, 53% had tried CT, and another 8% were planning to do so. The rates of use among the categories were not significantly different from those at baseline. A slightly higher percentage of respondents had tried or were planning to try physical methods at follow-up (22%) than at baseline, and slightly fewer were using spiritual methods (2%); otherwise, the pattern of use reported at baseline remained the same.
Satisfaction and CT Use
Satisfaction ratings are presented in Table 2 . On average, satisfaction with treatment decision making was high, with a mean score of 15.6 (SD = 3.4; range, [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . Most women reported that they were satisfied or very satisfied with the amount of time they had to make treatment decisions (92%) and with their degree of participation in the decision-making process (93%). However, more than half of the women (61%) reported that they would have liked assistance with knowing what questions to ask. In addition, some women reported that they would have liked more information about the side effects associated with chemotherapy (36%) or about treatment options (30%).
With regard to the patients' satisfaction with their medical oncologist, most of the women (81%) were very satisfied and another 14% were somewhat satisfied. Because the distribution of responses was heavily skewed in that most patients reported being very satisfied with their oncologist, this variable was coded as 0 = less than very satisfied and 1 = very satisfied. Of the 19% of patients who reported being less than very satisfied, 35% indicated that their medical oncologist did not answer their questions or provide information, and 11% reported that she or he did not provide clear explanations. Also, 19% perceived that their medical oncologist was incompetent; 19% reported that their oncologist was unsympathetic, discourteous, or lacking compassion; 8% thought the oncologist did not advocate for or support the patient; and 8% reported that the oncologist did not accommodate their needs. The results of the ANOVA (see Table 3 ) revealed that satisfaction with the treatment decision-making process was significantly related to CT use. Specifically, satisfaction scores for patients who were using or planning to use CT (n = 84; x -= 15.0, SD = 3.2) were significantly lower than those not using CT (n = 82; x -= 16.1, SD = 3.4; P < .05). Also, satisfaction with one's medical oncologist was significantly related to CT use: significantly fewer of the patients using or planning to use CT (72.3%, n = 94) reported being very satisfied with their oncologist versus patients not using CT (93.3%, n = 60; P < .01).
The results of the logistic regression analyses (see Table 4 ) revealed that women who were younger (P < .01), had more education (P < .05), had attended a support group (P < .05), and/or were less satisfied with treatment decision making (P < .05) were significantly more likely to have tried or be planning to try CT at baseline. There was also a trend indicating that women with higher income and earlier stage cancer were more likely to have tried or be planning to try CT; other demographic and psychosocial variables were not associated with CT use at baseline. Most women who were using CT at baseline were also using CT at follow-up; CT use at baseline was the strongest predictor of CT use at follow-up (P < .001). Also, patients who reported being less than very satisfied with their oncologist were significantly more likely to be using or planning to use CT (P < .05). Finally, support group attendance at baseline was associated with a higher likelihood of CT use at follow-up (P < .05).
Discussion
More than half of the women in this sample used or planned to use CT, and CT use increased from baseline to follow-up. Similar to previous studies, nutritional regimens, herbs, and vitamins were by far the most common types of CT used by women with breast cancer. 5, [23] [24] [25] [26] Our findings suggest that patient dissatisfaction with the treatment decision-making process at the beginning of chemotherapy treatment, as well as dissatisfaction with the oncologist approximately 4 months after starting chemotherapy, at least partly explain the use of CT. These findings are similar to those of other studies of younger women with breast cancer in which CT use was found to be associated with overall treatment satisfaction. 32, 51 At the follow-up assessment, most patients reported being very satisfied with their oncologist; this finding is similar to other reports in which satisfaction ratings tended to be high. 52 Of the small percentage that did report some dissatisfaction, most seemed to indicate problems with the physicianpatient relationship and/or communication problems; for example, they did not receive enough information or enough compassion/emotional support from their physician. The results of a qualitative study suggest that the interaction between physicians and younger women with breast cancer can be difficult. For example, some patients considered their physicians to be paternalistic in their communication style, and others reported that the interaction with their physician was the most traumatic aspect of the breast cancer experience. 11 Cohort differences in socialization experiences may be responsible for this disconnect between younger women and their physicians, particularly if the treating oncologist is considerably older than his or her patient and/or is more accustomed to treating older breast cancer patients. Research comparing the preferences of older and younger women with breast cancer for participation in treatment decision making has shown that older women are less likely than their younger counterparts to seek out medical information or to desire participation in medical treatment decision making. 53 Dissatisfaction with treatment decision making and the oncologist-patient relationship may influence not only the use of CT but also disclosure of such use to the physician. Studies have documented a lack of communication between cancer patients and their physicians about CT. 54, 55 The correlation between good physician-patient communication and increased patient satisfaction has been established. 52 The importance of communication about CT use is clear: while most women who report using CT cite methods that are benign (eg, prayer and exercise), use of other methods may carry some danger to women's health. For example, not only is there a lack of scientific evidence supporting the efficacy of many herbal and nutritional supplements, 56 but in fact, some herbal and vitamin remedies (eg, ginger, highdose vitamin A) may be dangerous and interfere with conventional cancer treatment. 9, 57, 58 Physicians with enhanced sensitivity to patients' need for information and participation preferences, especially during treatment decision making, may ease the stress of the situation and open the communication channels about CT use and other important issues, thereby improving the quality of patient care.
The limitations of this study include the fact that these data were collected more than 6 years ago; the attitudes and tendencies toward CT use among breast cancer patients may have changed since then. Also, the survey for this study was developed in the mid-1990s while definitions of "alternative" and "complementary" therapies were still being developed. Since the word complementary indicates the use of therapies used in conjunction with standard medical care, this survey should not have included the word alternative when being given to patients undergoing chemotherapy. More recent research now includes a definition of CT, 25, 26 and future studies should do so as well. In addition, patients were not asked to indicate whether they were using CT before their cancer diagnosis. It is possible that patients who are dissatisfied with their care are also experiencing physical and/or emotional difficulties beyond what was evaluated in this report. Perhaps some patients present with a constellation of symptoms such as pain, fatigue, and anxiety, along with additional psychosocial stressors (eg, financial strain, family and work difficulties) that in combination lead them toward seeking out CT. Or these patients had learned about the helpfulness of some CT through other patients, family, and/or friends or were already using some form of CT prior to their cancer diagnosis.
In summary, despite the study limitations, the findings from this report are useful in that they suggest that satisfaction with the cancer treatment experience, an area that has not been extensively studied, may influence the use of CT. Patient satisfaction with medical decision making, and with the oncologist, should continue to be considered in research investigating the reasons that cancer patients employ CT. The reasons that cancer patients use CT make up a multifaceted, complicated picture that requires further investigation.
